These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26108882)

  • 1. The history and rationale of using carbonic anhydrase inhibitors in the treatment of peptic ulcers. In memoriam Ioan Puşcaş (1932-2015).
    Buzás GM; Supuran CT
    J Enzyme Inhib Med Chem; 2016 Aug; 31(4):527-33. PubMed ID: 26108882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbonic anhydrase inhibitors: the beta-carbonic anhydrase from Helicobacter pylori is a new target for sulfonamide and sulfamate inhibitors.
    Nishimori I; Minakuchi T; Kohsaki T; Onishi S; Takeuchi H; Vullo D; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3585-94. PubMed ID: 17482815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the alpha-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs.
    Nishimori I; Minakuchi T; Morimoto K; Sano S; Onishi S; Takeuchi H; Vullo D; Scozzafava A; Supuran CT
    J Med Chem; 2006 Mar; 49(6):2117-26. PubMed ID: 16539401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Historical perspective of gastric acid inhibition.
    Díaz-Rubio M
    Drugs; 2005; 65 Suppl 1():1-6. PubMed ID: 16335852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel carbonic anhydrase inhibitors for the treatment of
    Supuran CT
    Expert Opin Investig Drugs; 2024 May; 33(5):523-532. PubMed ID: 38517734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbonic anhydrase inhibitors: cloning and sulfonamide inhibition studies of a carboxyterminal truncated alpha-carbonic anhydrase from Helicobacter pylori.
    Nishimori I; Vullo D; Minakuchi T; Morimoto K; Onishi S; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2182-8. PubMed ID: 16459077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Helicobacter pylori -- 2010].
    Buzás GM
    Orv Hetil; 2010 Dec; 151(49):2003-10. PubMed ID: 21106480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From nerves and hormones to bacteria in the stomach; Nobel prize for achievements in gastrology during last century.
    Konturek SJ; Konturek PC; Brzozowski T; Konturek JW; Pawlik WW
    J Physiol Pharmacol; 2005 Dec; 56(4):507-30. PubMed ID: 16391411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Historical impact to drive research in peptic ulcer disease.
    Banić M; Malfertheiner P; Babić Z; Ostojić R; Kujundzic M; Fatović-Ferenčić S; Plesko S; Petričušić L
    Dig Dis; 2011; 29(5):444-53. PubMed ID: 22095008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
    Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori and its involvement in gastritis and peptic ulcer formation.
    Konturek SJ; Konturek PC; Konturek JW; Plonka M; Czesnikiewicz-Guzik M; Brzozowski T; Bielanski W
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():29-50. PubMed ID: 17033104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The alpha and beta classes carbonic anhydrases from Helicobacter pylori as novel drug targets.
    Nishimori I; Onishi S; Takeuchi H; Supuran CT
    Curr Pharm Des; 2008; 14(7):622-30. PubMed ID: 18336307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural Basis for the Inhibition of Helicobacter pylori α-Carbonic Anhydrase by Sulfonamides.
    Modak JK; Liu YC; Machuca MA; Supuran CT; Roujeinikova A
    PLoS One; 2015; 10(5):e0127149. PubMed ID: 26010545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the alpha- and beta-carbonic anhydrases from the gastric pathogen Helycobacter pylori with anions.
    Maresca A; Vullo D; Scozzafava A; Supuran CT
    J Enzyme Inhib Med Chem; 2013 Apr; 28(2):388-91. PubMed ID: 22299578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Healing peptic ulcer disease with therapy of Helicobacter pylori infection--an overview].
    Leodolter A; Peitz U; Malfertheiner P
    Wien Med Wochenschr; 2001; 151(13-14):300-8. PubMed ID: 11582994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental production of peptic ulcer, gastric damage and cancer models and their use in pathophysiological studies and pharmacological treatment--Polish achievements.
    Brzozowski T
    J Physiol Pharmacol; 2003 Dec; 54 Suppl 3():99-126. PubMed ID: 15075467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A class of sulfonamide carbonic anhydrase inhibitors with neuropathic pain modulating effects.
    Carta F; Di Cesare Mannelli L; Pinard M; Ghelardini C; Scozzafava A; McKenna R; Supuran CT
    Bioorg Med Chem; 2015 Apr; 23(8):1828-40. PubMed ID: 25766630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbonic anhydrase inhibitors.
    Supuran CT
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3467-74. PubMed ID: 20529676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the carbonic anhydrase inhibitor, acetazolamide, on Helicobacter pylori infection in vivo: a pilot study.
    Shahidzadeh R; Opekun A; Shiotani A; Graham DY
    Helicobacter; 2005 Apr; 10(2):136-8. PubMed ID: 15810944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glaucoma and the applications of carbonic anhydrase inhibitors.
    Scozzafava A; Supuran CT
    Subcell Biochem; 2014; 75():349-59. PubMed ID: 24146387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.